Anti‐neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Hepatology

• Publication date

  1997-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.510250510PMID 9141425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis

  2005cited by this paper
• Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques.

  1995cited by this paper
• Autoimmune hepatitis. Evolving concepts and treatment strategies.

  1995cited by this paper
• Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis

  1995cited by this paper
• High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

  1995cited by this paper
• The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens

  1995cited by this paper
• The validity and importance of subtypes in autoimmune hepatitis: a point of view.

  1995cited by this paper
• Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.

  1994cited by this paper
• Autoimmune hepatitis and hepatitis C virus infection.

  1994cited by this paper
• Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994.

  1994cited by this paper
• Meeting report: International autoimmune hepatitis group

  1993cited by this paper
• Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis.

  1993cited by this paper
• Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

  1993cited by this paper
• Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.

  1992cited by this paper
• Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

  1992cited by this paper
• Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

  1992cited by this paper
• Type 2 autoimmune hepatitis and hepatitis C virus infection.

  1990cited by this paper
• Anti-actin antibodies: a new test for an old problem.

  1990cited by this paper
• Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.

  1982cited by this paper

• Pathophysiological Differences and Differential Diagnosis of Autoimmune and Drug-Induced Hepatitis

  2025cites this paper
• Association of atypical anti-neutrophil cytoplasmic antibody with comorbidities and outcome in a hospital-based population

  2024cites this paper
• Bilateral Choroidal Detachments Associated with Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) – Associated Vasculitis

  2024cites this paper
• Evaluation of autoimmune liver disease antibodies in hepatitis patients

  2024cites this paper
• Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study

  2024cites this paper
• Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis

  2023cites this paper
• Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis.

  2022cites this paper
• B cells in autoimmune hepatitis: bystanders or central players?

  2022cites this paper
• Studying of Some Physiological Parameters in Patients with Inflammatory Bowel Disease ( IBD ) in Al-Anbar Province

  2022cites this paper
• Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting.

  2021cites this paper
• Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis

  2021cites this paper
• Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis

  2021cites this paper
• Seronegative autoimmune hepatitis in children

  2021cites this paper
• Primary Sclerosing Cholangitis

  2020cites this paper
• 2020 international consensus on ANCA testing beyond systemic vasculitis.

  2020cites this paper
• Clinical Presentation and Diagnosis

  2020cites this paper
• Diagnosis and Management of Autoimmune Hepatitis: A Clinical Guide

  2020cites this paper
• Autoimmunity in Indeterminate Etiologies of Acute Liver Failure: Is This Autoimmune Liver Disease or an Autoimmune Phenotype to Drug Toxicity?

  2020cites this paper
• Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions

  2019cites this paper
• Cellular and Molecular Mechanisms of Autoimmune Hepatitis.

  2018cites this paper
• The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.

  2018cites this paper
• Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management

  2018cites this paper
• 8 – Autoimmune Hepatitis

  2018cites this paper
• Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees.

  2017cites this paper
• Diagnostic approach to autoimmune hepatitis

  2017cites this paper
• Serology in autoimmune hepatitis: A clinical-practice approach.

  2017cites this paper
• [Practice guideline autoimmune liver diseases - AWMF-Reg. No. 021-27].

  2017cites this paper
• S2k Leitlinie Autoimmune Lebererkrankungen

  2017cites this paper
• Ein positiver ANA/ANCA-Befund – es muss nicht immer eine Kollagenose sein

  2017cites this paper
• Autoimmune Liver Diseases: Autoimmune Hepatitis

  2017cites this paper
• Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases.

  2017cites this paper
• Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy.

  2016cites this paper
• PR3 antibodies: not always an immunological emergency.

  2016cites this paper
• Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions

  2016cites this paper
• Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis

  2016cites this paper
• Relative Rarity of Autoimmune Liver Disease Compared with Viral Hepatitis in A Sub-Saharan Black Population

  2016cites this paper
• EASL Clinical Practice Guidelines: Autoimmune hepatitis.

  2015influential citation
• Clinical aspects of indirect immunofluorescence for autoimmune diseases

  2015cites this paper
• Transitioning from Idiopathic to Explainable Autoimmune Hepatitis

  2015cites this paper
• The Spectrum of Hepatic Involvement in Pediatric Inflammatory Bowel Disease: An Analysis of the Development of Abnormal Liver Enzymes and Associated Clinical Variables

  2014cites this paper
• Features of Autoimmune Hepatitis in Egyptian Children

  2013cites this paper
• Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis.

  2013cites this paper
• A seroimmunological profile of erosive hand osteoarthritis.

  2013cites this paper
• Glomerular Disease in Patients with Infectious Processes Developing Antineutrophil Cytoplasmic Antibodies

  2013cites this paper
• Clinical features in different age groups of patients with autoimmune hepatitis

  2013cites this paper
• Review article: autoimmune hepatitis – current management and challenges

  2013cites this paper
• Liver Disease in Pediatric Inflammatory Bowel Disease

  2013cites this paper
• article : autoimmune hepatitis – current management and challenges

  2013cites this paper
• Serum Autoantibodies in Chronic Hepatitis C : Comparison with Hepatitis C / Autoimmune Hepatitis Overlap Syndrome in Egypt

  2012cites this paper
• Autoantibody-Negative Autoimmune Hepatitis

  2012cites this paper
• 9 – Autoimmune hepatitis

  2012cites this paper
• CHAPTER 46 – Gastrointestinal: Liver

  2011cites this paper
• British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

  2011cites this paper
• Current and future role of biomarkers in Crohn’s disease risk assessment and treatment

  2011cites this paper
• Diagnosis and management of autoimmune hepatitis

  2010cites this paper
• Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin

  2010cites this paper
• p-ANCAs in autoimmune liver disorders recognise human β-tubulin isotype 5 and cross-react with microbial protein FtsZ

  2009cites this paper
• The Serological Profile of the Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome

  2009cites this paper
• Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

  2009cites this paper
• Approach to diagnosis of auto-immune hepatitis.

  2009cites this paper
• Autoimmune hepatitis in Italy: the Bologna experience.

  2009cites this paper
• Atypical p-ANCA in PSC and AIH: A Hint Toward a “leaky gut”?

  2009cites this paper
• Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.

  2009cites this paper
• What is behind the presence of anti‐neutrophil cytoplasmatic antibodies in chronic liver disease?

  2009cites this paper
• Diagnosis and therapy of autoimmune hepatitis.

  2009cites this paper
• Autoimmune liver disease 2007.

  2008cites this paper
• Autoimmune Hepatitis and PSC Connection.

  2008cites this paper
• Auto-anticuerpos en las enfermedades hepáticas

  2007cites this paper
• Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance

  2007cites this paper
• Cryoglobulinemia Related to Hepatitis C Virus Infection

  2007cites this paper
• AutoimmuneHepatitis Associated with Graves' Disease

  2007cites this paper
• B cells and autoimmune liver diseases.

  2006cites this paper
• The role of autoantibodies as diagnostic markers of autoimmune hepatitis

  2006cites this paper
• Anti‐cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis

  2005cites this paper
• [Autoimmune hepatitis associated with Crohn's disease and cytoplasmic antineutrophilic cytoplasmic antibodies].

  2005cites this paper
• Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.

  2005cites this paper
• Autoantibodies in autoimmune liver disease.

  2005cites this paper
• Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases

  2005cites this paper
• Serological diagnosis of autoimmune hepatobiliary diseases.

  2005cites this paper
• Anti‐Saccharomyces cerevisiae and perinuclear anti‐neutrophil cytoplasmic antibodies in coeliac disease before and after gluten‐free diet

  2005cites this paper
• Hepatitis autoinmune asociada a enfermedad de Crohn y anticuerpos anticitoplasma de los neutrófilos con patrón citoplásmico

  2005cites this paper
• Autoimmune hepatitis: a childhood disease

  2005cites this paper
• Occupational exposure in ANCA-positive patients: a case-control study.

  2005cites this paper
• HEPATIC DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS: COINCIDENCE OR CONVERGENCE

  2004cites this paper
• Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.

  2004cites this paper
• Graves' disease accompanied by anti-myeloperoxidase antibody-related nephropathy and autoimmune hepatitis.

  2004cites this paper
• Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.

  2004cites this paper
• Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease

  2004influential citation
• A novel IgM class autoantibody to a hepatocyte‐related 190 kDa molecule in patients with type 1 autoimmune hepatitis

  2004cites this paper
• [Hepatitis of unknown origin with protracted liver failure in a 48-year-old patient with significantly increased pANCA titer].

  2003cites this paper
• Frequency and Significance of Antibodies to Chromatin in Autoimmune Hepatitis

  2003cites this paper
• Anti‐Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases

  2003cites this paper
• Clinical manifestations of autoimmune liver diseases in Korea

  2003cites this paper
• Unklare Hepatitis mit protrahiertem Leberversagen bei einem 48-jährigen Patienten mit deutlich erhöhtem pANCA-Titer

  2003cites this paper
• Autoantibodies in the diagnosis and management of liver disease.

  2003cites this paper
• Characterization and Clinical Impact of Antinuclear Antibodies in Primary Biliary Cirrhosis

  2003cites this paper
• Autoimmune hepatitis associated with Graves' disease.

  2003cites this paper
• Methodenvergleich zum Nachweis von 'Anti-Neutrophil-Cytoplasmic Antibodies' (ANCA) und klinische Relevanz der ANCA bei Patienten mit chronischen Erkrankungen unter besonderer Berücksichtigung autoimmuner Lebererkrankungen

  2003cites this paper
• IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis

  2003cites this paper
• Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.

  2002cites this paper